The Shreveport Myeloma Experience: Survival, Risk Factors and Other Malignancies in the Age of Stem Cell Transplantation

Publisher： Karger

E-ISSN： 1421-9662|135|3|146-155

ISSN： 0001-5792

Source： Acta Haematologica, Vol.135, Iss.3, 2015-11, pp. : 146-155

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Incidence and Risk Factors of Bisphosphonate-Related Osteonecrosis of the Jaw in Multiple Myeloma Patients Having Undergone Autologous Stem Cell Transplantation

By  

Oncology Research and Treatment, Vol. 35, Iss. 11, 2012-10 ,pp. : 658-664

Karger

Access to resources Recommend Favorite

Survival of Multiple Myeloma Patients Aged 65-70 Years in the Era of Novel Agents and Autologous Stem Cell Transplantation

By  

Acta Haematologica, Vol. 132, Iss. 2, 2014-03 ,pp. : 211-219

Karger

Access to resources Recommend Favorite

Allogeneic Hematopoietic Stem Cell Transplantation: An Option for Long-Term Survival for Patients with Simultaneous Appearance of Myeloid and Lymphatic Malignancies

By  

Acta Haematologica, Vol. 129, Iss. 3, 2012-11 ,pp. : 135-136

Karger

Access to resources Recommend Favorite

Outcome in Multiple Myeloma Patients Eligible for Stem Cell Transplantation: A Single-Center Experience

By  

Oncology, Vol. 89, Iss. 4, 2015-07 ,pp. : 196-204

Karger

Access to resources Recommend Favorite

Second Allogeneic Stem Cell Transplantation in Myeloid Malignancies

By  

Acta Haematologica, Vol. 122, Iss. 4, 2009-10 ,pp. : 185-192

Karger

Access to resources Recommend Favorite